The $762 Million Settlement: Inside the Amgen Whistleblower Case

Overview

In December 2012, pharmaceutical giant Amgen agreed to pay $762 million to resolve criminal and civil liability arising from illegal drug marketing practices. Ten whistleblowers came forward with evidence of off-label promotion and kickbacks.

In this episode, we examine how these cases were built, combined by the Department of Justice, and ultimately led to one of the largest pharmaceutical settlements in history.